New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F25%3A43928033" target="_blank" >RIV/00064173:_____/25:43928033 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/25:10491592 RIV/00216208:11120/25:43928033 RIV/00064165:_____/25:10491592

Výsledek na webu

<a href="https://doi.org/10.1055/a-2494-8395" target="_blank" >https://doi.org/10.1055/a-2494-8395</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1055/a-2494-8395" target="_blank" >10.1055/a-2494-8395</a>

Jazyk výsledku

angličtina

Název v původním jazyce

New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic

Popis výsledku v původním jazyce

The International Federation of Gynaecology and Obstetrics (FIGO) introduced a new staging system for endometrial carcinoma FIGO 2023 in June 2023. The new staging system differs significantly from previous versions by incorporating other non-anatomical parameters (histological type of tumour, tumour grade and the presence of massive lymphovascular space involvement as well as the molecular classification of the tumour). The FIGO 2023 staging system enhances the accuracy of prognostic assessments for patients at a specific stage with better options for targeted treatment. Another objective was to synchronise staging as much as possible with the European oncogynaecological ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma established in 2021. However, several changes are controversial. Routine molecular classification of endometrial carcinomas is not yet commonly available in most countries of the world. Another limitation of the FIGO 2023 staging system of endometrial cancer is the inclusion of variables whose definitions are still evolving, as well as variables that are subject to considerable interobserver variability in their assessment. Advantages, controversies, and limitations for clinical practice of the new FIGO 2023 endometrial cancer staging system are discussed.

Název v anglickém jazyce

New FIGO 2023 Staging System of Endometrial Cancer: An Updated Review on a Current Hot Topic

Popis výsledku anglicky

The International Federation of Gynaecology and Obstetrics (FIGO) introduced a new staging system for endometrial carcinoma FIGO 2023 in June 2023. The new staging system differs significantly from previous versions by incorporating other non-anatomical parameters (histological type of tumour, tumour grade and the presence of massive lymphovascular space involvement as well as the molecular classification of the tumour). The FIGO 2023 staging system enhances the accuracy of prognostic assessments for patients at a specific stage with better options for targeted treatment. Another objective was to synchronise staging as much as possible with the European oncogynaecological ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma established in 2021. However, several changes are controversial. Routine molecular classification of endometrial carcinomas is not yet commonly available in most countries of the world. Another limitation of the FIGO 2023 staging system of endometrial cancer is the inclusion of variables whose definitions are still evolving, as well as variables that are subject to considerable interobserver variability in their assessment. Advantages, controversies, and limitations for clinical practice of the new FIGO 2023 endometrial cancer staging system are discussed.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30204 - Oncology

Projekt

<a href="/cs/project/NW24-09-00505" target="_blank" >NW24-09-00505: Molekulární klasifikace ve vztahu k prevenci rekurence karcinomu endometria a life style faktorům</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Geburtshilfe und Frauenheilkunde

ISSN

0016-5751

e-ISSN

1438-8804

Svazek periodika

85

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

12

Strana od-do

405-416

Kód UT WoS článku

001398153500001

EID výsledku v databázi Scopus

2-s2.0-85216348336